Skip to main content
ConductScienceScienceDex

Christopher H Van Dyck

NIH Rank #293
Unclaimed recordClaim profile
  • Program Leader
  • Top 5% Funded
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1937838Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2025

Linked Award Amount
$12.3M
Full award amounts, FY2025
Award Records
2
Records listing this PI
Award-Linked Rank
#293
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Christopher H Van Dyck. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Christopher H Van Dyck as a PI. Multi-PI records show the full award amount for context.

  • 5R01AG065248-04R01
    Randomized Double Blind, Placebo Controlled, Parallel Group Trial to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease over 18 Months
    Cognition Therapeutics, Inc.
    $12M
    award amount
  • 2P30AG066508-06P30
    Yale Alzheimer Disease Research Center
    Yale University
    $360.1K
    award amount

Award organizations

Organizations that administered FY2025 awards listing Christopher H Van Dyck as a PI.

Cognition Therapeutics, Inc.
PA
$12M
1 grant
Yale University
CT
$360.1K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Cognition Therapeutics, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    $10M Cumulative Funding
  7. 2024
    Entered Top 50% Nationally
    Ranked #198
  8. 2024
    Entered Top 25% Nationally
    Ranked #198
  9. 2024
    Entered Top 10% Nationally
    Ranked #198
  10. 2024
    Entered Top 5% Nationally
    Ranked #198
  11. 2024
    Entered Top 1% Nationally
    Ranked #198
  12. 2025
    $25M Cumulative Funding
  13. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  14. 2025
    R01 Grant Holder
  15. 2025
    Program/Center Grant Leader

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Christopher H Van Dyck.

Anita Juliane Huttner
Yale University
3
shared awards
Heather Gwynn Allore
Yale University
3
shared awards
Jaime Grutzendler
Yale University
3
shared awards
Richard Marottoli
Yale University
3
shared awards
Stephen M Strittmatter
Yale University
3
shared awards
Anthony O Caggiano
Cognition Therapeutics, Inc.
2
shared awards
Georges El Fakhri
Yale University
2
shared awards
Paul S. Aisen
Cognition Therapeutics, Inc.
2
shared awards
Angus C. Nairn
Yale University
1
shared award
Richard E. Carson
Yale University
1
shared award

Explore further

Find collaborators for Christopher H Van Dyck

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →